NCT02233699View on ClinicalTrials.gov

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

PHASE2CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Chronic Idiopathic Cough

Interventions

DRUG

XEN-D0501

DRUG

Placebo

Trial Locations (2)

BT9 7AB

Belfast City Hospital, Belfast

M23 9LT

University Hospital of South Manchester, Manchester

Sponsors

Collaborators (1)

Ario Pharma Ltd

All Listed Sponsors

collaborator

Ario Pharma Ltd

INDUSTRY

lead

Xention Ltd

INDUSTRY

NCT02233699 - A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough | Biotech Hunter | Biotech Hunter